Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
907
-
Total 13F shares, excl. options
-
172,806,261
-
Shares change
-
+1,631,100
-
Total reported value, excl. options
-
$31,924,084,222
-
Value change
-
+$289,583,036
-
Put/Call ratio
-
96%
-
Number of buys
-
377
-
Number of sells
-
-436
-
Price
-
$184.74
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2019
1,041 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2019.
Edwards Lifesciences Corp - Common Stock (EW) has 907 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 172,806,261 shares
of 590,231,680 outstanding shares and own 29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16,513,521 shares), VANGUARD GROUP INC (15,978,511 shares), STATE STREET CORP (8,840,451 shares), FMR LLC (7,949,388 shares), SANDS CAPITAL MANAGEMENT, LLC (7,501,408 shares), Bank of New York Mellon Corp (6,814,840 shares), JENNISON ASSOCIATES LLC (6,039,006 shares), Capital Research Global Investors (5,115,601 shares), WELLINGTON MANAGEMENT GROUP LLP (4,810,030 shares), and ALLIANCEBERNSTEIN L.P. (4,363,733 shares).
This table shows the top 907 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.